85 related articles for article (PubMed ID: 38741178)
1. Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer.
Hsieh JJ; Manley BJ; Khan N; Gao J; Carlo MI; Cheng EH
Semin Cell Dev Biol; 2017 Apr; 64():98-106. PubMed ID: 27615548
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles.
Grützmann K; Salomo K; Krüger A; Lohse-Fischer A; Erdmann K; Seifert M; Baretton G; Aust D; William D; Schröck E; Thomas C; Füssel S
Biol Direct; 2024 May; 19(1):38. PubMed ID: 38741178
[TBL] [Abstract][Full Text] [Related]
3. Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma.
Lasorsa F; Rutigliano M; Milella M; Ferro M; Pandolfo SD; Crocetto F; Tataru OS; Autorino R; Battaglia M; Ditonno P; Lucarelli G
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373581
[TBL] [Abstract][Full Text] [Related]
4. Role of tumor-derived exosomes in metastasis, drug resistance and diagnosis of clear cell renal cell carcinoma.
Jiang T; Zhu Z; Zhang J; Chen M; Chen S
Front Oncol; 2022; 12():1066288. PubMed ID: 36620603
[TBL] [Abstract][Full Text] [Related]
5. Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets.
di Meo NA; Lasorsa F; Rutigliano M; Loizzo D; Ferro M; Stella A; Bizzoca C; Vincenti L; Pandolfo SD; Autorino R; Crocetto F; Montanari E; Spilotros M; Battaglia M; Ditonno P; Lucarelli G
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430837
[TBL] [Abstract][Full Text] [Related]
6. SNHG25 facilitates SNORA50C accumulation to stabilize HDAC1 in neuroblastoma cells.
Zeng H; Pan J; Hu C; Yang J; Li J; Tan T; Zheng M; Shen Y; Yang T; Deng Y; Zou Y
Cell Death Dis; 2022 Jul; 13(7):597. PubMed ID: 35821006
[TBL] [Abstract][Full Text] [Related]
7. The Preliminary Exploration of What Role miRNAs Derived From Urinary Exosomes Play in Kidney Stone Formation.
Yang Y; Wang Q; Xun Y; Li C; Wang S
Urology; 2022 Aug; 166():104-110. PubMed ID: 35636636
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles-A New Potential Player in the Immunology of Renal Cell Carcinoma.
Kleibert M; Majka M; Łakomska K; Czystowska-Kuźmicz M
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629194
[TBL] [Abstract][Full Text] [Related]
9. Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model.
Cai C; Peng Y; Shen E; Wan R; Gao L; Gao Y; Zhou Y; Huang Q; Chen Y; Liu P; Guo C; Feng Z; Zhang X; Liu Y; Shen H; Zeng S; Han Y
EBioMedicine; 2022 Feb; 76():103866. PubMed ID: 35144219
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar Proteins and Non-Coding RNAs: Roles in Renal Cancer.
Popławski P; Bogusławska J; Hanusek K; Piekiełko-Witkowska A
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884928
[TBL] [Abstract][Full Text] [Related]
11. Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
Zieren RC; Dong L; Clark DJ; Kuczler MD; Horie K; Moreno LF; Lih TM; Schnaubelt M; Vermeulen L; Zhang H; de Reijke TM; Pienta KJ; Amend SR
Med Oncol; 2021 Jul; 38(9):105. PubMed ID: 34331598
[TBL] [Abstract][Full Text] [Related]
12. Small nucleolar RNA host genes promoting epithelial-mesenchymal transition lead cancer progression and metastasis.
Biagioni A; Tavakol S; Ahmadirad N; Zahmatkeshan M; Magnelli L; Mandegary A; Samareh Fekri H; Asadi MH; Mohammadinejad R; Ahn KS
IUBMB Life; 2021 Jun; 73(6):825-842. PubMed ID: 33938625
[TBL] [Abstract][Full Text] [Related]
13. Profiling of Serum Extracellular Vesicles Reveals
Muramatsu-Maekawa Y; Kawakami K; Fujita Y; Takai M; Kato D; Nakane K; Kato T; Tsuchiya T; Koie T; Miura Y; Ito M; Mizutani K
Cancer Genomics Proteomics; 2021; 18(3):253-259. PubMed ID: 33893078
[TBL] [Abstract][Full Text] [Related]
14. SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.
Yu H; Liu J; Zhang Z; Zhu Y; Bi J; Kong C
J Cell Mol Med; 2021 May; 25(10):4696-4708. PubMed ID: 33787057
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
Tian P; Wei JX; Li J; Ren JK; Yang JJ
Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
[TBL] [Abstract][Full Text] [Related]
16. SNORD63 and SNORD96A as the non-invasive diagnostic biomarkers for clear cell renal cell carcinoma.
Shang X; Song X; Wang K; Yu M; Ding S; Dong X; Xie L; Song X
Cancer Cell Int; 2021 Jan; 21(1):56. PubMed ID: 33461545
[TBL] [Abstract][Full Text] [Related]
17. Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade.
Motzer RJ; Banchereau R; Hamidi H; Powles T; McDermott D; Atkins MB; Escudier B; Liu LF; Leng N; Abbas AR; Fan J; Koeppen H; Lin J; Carroll S; Hashimoto K; Mariathasan S; Green M; Tayama D; Hegde PS; Schiff C; Huseni MA; Rini B
Cancer Cell; 2020 Dec; 38(6):803-817.e4. PubMed ID: 33157048
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Derived from Circulating Exosomes as Noninvasive Biomarkers for Diagnosing Renal Cell Carcinoma.
Xiao CT; Lai WJ; Zhu WA; Wang H
Onco Targets Ther; 2020; 13():10765-10774. PubMed ID: 33122915
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
